Idiopathic Pulmonary Fibrosis, 1st Edition
Designed with the practicing clinician in mind, Idiopathic Pulmonary Fibrosis provides a succinct, easy-to-digest overview of this challenging condition in which the cause of thickening lung tissue is unknown. This concise resource by Drs. Kevin K. Brown and Jeff Swigris provides essential information for the physician who sees pulmonary fibrosis patients, including epidemiology, genetics and biomarkers, pathology, diagnosis, disease monitoring, and therapeutics intended to improve the patient’s lifespan and quality of life.
Designed with the practicing clinician in mind, Idiopathic Pulmonary Fibrosis provides a succinct, easy-to-digest overview of this challenging condition in which the cause of thickening lung tissue is unknown. This concise resource by Drs. Kevin K. Brown and Jeff Swigris provides essential information for the physician who sees pulmonary fibrosis patients, including epidemiology, genetics and biomarkers, pathology, diagnosis, disease monitoring, and therapeutics intended to improve the patient’s lifespan and quality of life.
特長
- Covers the process of making the diagnosis of idiopathic pulmonary fibrosis, as well as IPF look-alikes: uncharacterized PF, CTD-ILD, and cHP.
- Details today’s available therapeutics, including Rx, rehabilitation, O2, Tx, and treating comorbidities: OSA, GERD, and PH.
- Consolidates today’s available information on this timely topic into one convenient resource.
著者情報
| ISBN Number | 9780323544320 |
|---|---|
| Description Author List | By Jeffrey Swigris and Kevin K Brown, MD, National Jewish Health |
| Copyright Year | 2019 |
| Edition Number | 1 |
| Format | E-Book |
| Trim | Other |
| Imprint | Elsevier |
| Page Count | 350 |
| Publication Date | 25 Jul 2018 |
| Stock Status | IN STOCK |
Preface
1. Introduction
2. Epidemiology of IPF/ILD
3. Mechanisms of Fibrosis
4. Genetics of IPF
5. HRCT in IPF
6. Pathology of IPF
7. Making the Diagnosis of IPF
8. IPF Look-Alikes: Uncharacterized PF, CTD-ILD and cHP
9. Natural History of IPF and Disease Monitoring
10. Biomarkers in IPF
11. Therapeutics (Rx, Rehabilitation, O2, Tx, and Treating Comorbidities: OSA, GERD, PH)
